Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | AMGN | VRTX | BMY | GILD |
| Company | Arcellx Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 80.22 | 316.16 | 483.00 | 55.14 | 89.64 |
| High | 87.74 | 319.52 | 503.20 | 56.28 | 90.39 |
| Low | 77.00 | 313.02 | 474.00 | 54.72 | 89.01 |
| Last | 87.12 | 319.29 | 499.88 | 55.95 | 90.22 |
| Change | +0.68 | +2.38 | +27.08 | +0.50 | +0.38 |
| % Change | +0.79% | +0.75% | +5.73% | +0.90% | +0.42% |
| Volume | 2,330,851 | 1,471,063 | 1,722,784 | 9,269,571 | 3,958,107 |
| 20-Day Average Volume | 592,163 | 1,721,998 | 1,072,929 | 8,714,349 | 5,156,730 |
| Previous Close | 86.44 | 316.91 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 87.83 | 319.72 | 478.91 | 53.23 | 87.52 |
| 20-Day Raw Stochastic | 49.27% | 46.71% | 92.93% | 93.36% | 92.51% |
| 20-Day Relative Strength | 56.08% | 48.10% | 60.80% | 64.02% | 69.82% |
| Weighted Alpha | +91.81 | +16.76 | +32.73 | +18.27 | +27.65 |
| Today's Opinion | 80% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 80% Buy | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.15% since 10/29/24 | +1.04% since 10/29/24 | +6.28% since 10/29/24 | +6.57% since 10/29/24 | +2.43% since 10/29/24 |
| Low | 77.00 on 11/05/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 91.20 on 11/04/24 | 323.40 on 10/31/24 | 503.20 on 11/05/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | +11.36% since 10/04/24 | -0.12% since 10/04/24 | +9.79% since 10/04/24 | +3.69% since 10/04/24 | +6.66% since 10/04/24 |
| Low | 75.15 on 10/07/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 97.54 on 10/18/24 | 329.17 on 10/11/24 | 503.20 on 11/05/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | +70.52% since 08/05/24 | -1.82% since 08/05/24 | +4.82% since 08/05/24 | +17.57% since 08/05/24 | +20.57% since 08/05/24 |
| Low | 50.29 on 08/07/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 97.54 on 10/18/24 | 339.17 on 09/23/24 | 503.20 on 11/05/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | +65.34% since 05/03/24 | +2.57% since 05/03/24 | +24.63% since 05/03/24 | +27.19% since 05/03/24 | +39.27% since 05/03/24 |
| Low | 47.88 on 05/10/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 97.54 on 10/18/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.28 on 11/05/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,646,669 | 170,284,928 | 122,030,624 | 112,462,416 | 111,850,072 |
| Shares Outstanding, K | 53,756 | 537,329 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 110,320,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -70,690,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 27,380,000 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -27,200,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | 0.27 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.51 on 08/08/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 46.43 | 19.04 |